As part of the transaction, Inflexion – a leading European mid-market private equity firm – will retain a minority shareholding in Medik8.
Driven by scientific research and innovation, Medik8 offers ingredient-led premium skincare, targeted to prominent online and offline retailers in Europe, with a growing presence in the US.
The new partnership with L'Oréal will allow Medik8 to deepen its presence in existing markets and expand globally.
The Simmons team advising Medik8 management was led by private equity partner Tim Hewens, supported by Alex Critchley (Counsel) and Linda Zeman (Counsel).
Tim Hewens commented: “Our role in advising the management of Medik8 in this major deal reflects our private equity and transactional expertise, as well as our wide experience operating in the healthcare and life sciences sector. We congratulate all parties on securing this very positive outcome”.
